BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2000

View Archived Issues

AstraZeneca and Cellomics collaborate on accelerating drug discovery

Read More

EntreMed establishes angiogenesis collaboration with Children's Hospital of Boston

Read More

ArQule and Monsanto extend and expand agreement

Read More

Genotropin delivery device now available for long-term replacement therapy in GHD

Read More

NCI to initiate phase III trial of Neovastat in the U.S. and Canada

Read More

Immunomedics' bispecific fusion proteins covered by U.S. patent

Read More

Recently issued patent covers Neurogens new selective dopamine D4 ligands

Read More

Novel anticonvulsants in development at SmithKline Beecham

Read More

Selective GABA-A ligands synthesized at MS&D for use particularly as nonsedating anxiolytics

Read More

Yoshitomi announces upcoming name change

Read More

Phase I results support efficacy of rhVEGF in producing therapeutic angiogenesis

Read More

Pfizer presents new series of JAK3 inhibitors for autoimmune diseases

Read More

Thienodipyridines useful for inflammatory and immune disorders designed at Takeda

Read More

New inhibitors of cGMP-PDE in development at BMS for ED and cardiovascular conditions

Read More

Takeda reveals new GnRH antagonists in recently issued patent

Read More

SB-269970: a potent and selective 5-HT7 receptor antagonist ligand

Read More

StemCells reports first direct isolation of human brain stem cells

Read More

New findings enhance validity of preclinical models for evaluating LHRH peptide conjugates

Read More

DuPont Pharma to acquire Canadian rights to Mallinckrodt's nuclear medicine products

Read More

Glaxo Wellcome and NeuroSearch to develop NS-2389 for treatment of depression

Read More

Cellegy expands Anogesic clinical trial for reduction of pain in hemorrhoidectomy

Read More

Pharmacia & Upjohn launches Aromasin breast cancer therapy in the U.S.

Read More

Georgetown University to study Magainin's squalamine for diabetic retinopathy

Read More

New treatment for CF now available in U.K. pharmacies

Read More

Antiinflammatory factor identified in glucocorticoid-treated human monocytes

Read More

Boehringer Ingelheim brings new angiotensin II antagonist to market in U.K.

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 10, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing